Globus Medical seems to be reverting to form, reporting a big jump in operating profit and profit margin for Q1, 2025. Here ...

A low-grade litigation between drug purchasers and big pharma is breaking out. The implications for orthopedic and spine surgery include drug availability (hospital, clinic or ASC), cost and access ...

MIT 0. In the latest skirmish between West Coast and East Coast over the #1 disruptive biotechnology, CRISPR, it is advantage ...

Dr. Kingsley R. Chin, the Founder, President and CEO of SpineFrontier, Inc., pleaded guilty on May 15, 2025, to one count of ...

In a groundbreaking advancement for the orthopedic device industry, Sawbones and Numalogics, Inc. are proud to announce that ...

Holy Moley Rocky! Pipsqueak pharmacy wins slam dunk verdict against Big Pharma—re: Ozempic and Wegovy?! Incredible story with ...

Massachusetts, are suing the Trump administration over NIH cuts alleging they violate law and principle. Is it too late for ...

Hurry to American College of Sports Medicine’s (ACSM) annual meeting in Atlanta, Georgia, May 27 through May 30. Book the flights now for the American College of Sports Medicine’s (ACSM) annual ...

It’s something you can’t buy more of. Answer: TIME. But not just clock time. Biologic Time. Very innovative research tackles ...

Stryker Corporation’s opening quarter of 2025 was, to paraphrase one Wall Street analysts, a “top, middle and bottom beat” ...

TKA patients should receive a higher DRG classification—469 vs 470. Why? Umm—They Cost More? Here’s the data—from a new NYU ...

States sue Trump’s HHS over massive cuts and staff terminations in public health agencies and programs. Will these suits have any chance of rolling the cuts back? Or is it too late? Stay tuned for ...